Latest news
-
08 March 2016 -
12 November 2015 Almac Group to Collaborate with Illumina on Next-Generation Sequencing Based Companion Diagnostic Development
Read more
-
10 July 2015 Almac Group Announce Companion Diagnostic Partnerships with OncoMed
Read more
-
03 March 2015 Almac Group Appoints Dr. Shirin Khambata Ford as VP Product Development
Read more
-
05 February 2015 Almac Appoints VP Quality and Regulatory Affairs
Read more
-
28 January 2014 Data Presented Supporting Almac Developed Colon Signature as a Significant Predictor of Risk of Recurrence in Stage II Colon Cancer
Read more
-
21 January 2014 Almac publishes breast cancer chemotherapy response assay in the Journal of the National Cancer Institute
Read more
-
26 November 2013 Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
Read more
-
10 September 2013 Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service
Read more